In vitro and in vivo antileishmanial activity of the hanging sedge flavonoids based on bio‐ guided fractionation assay
Chemical Biology & Drug Design · 2023
DOI: 10.1111/cbdd.14226 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2023. Verfasst von Neda Moradian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Parasitology and Mycology, School of Medicine Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Leishmaniasis, Cutaneous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Shiraz University of Medical Sciences.
Abstract (Originalsprache)
As a major public health issue, cutaneous leishmaniasis (CL) has a number of complications, including drug resistance and poor response to conventional treatments. Over the last decade, research on natural sources for finding new antileishmanial agents has been a critical part of tropical disease research. Natural products also should be regarded as one of the most valuable applications for CL infection drug development. In this study, we assessed the in vitro and in vivo antileishmanial potential of Carex pendula Huds. (hanging sedge) methanolic extract and its fractions against Leishmania major produced cutaneous infection. Although the methanolic extract and its fractions exhibited suitable activity, the ethyl acetate fraction showed the best activity (with the half maximal inhibitory concentration IC 50 = 1.627 ± 0.211 mg/mL). The toxicity and selectivity indices (SI) of all samples were determined in murine peritoneal macrophage cells (J774A.1) using the 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) test. The flavonoid components of the ethyl acetate fraction were identified using liquid chromatography electrospray ionization mass spectrometry (LC‐ESI MS/MS). Nine chemical compounds were identified in this fraction, including three flavonols, four flavanonols, and two flavan derivatives. L. major ‐infected mice were used as an in vivo model because the methanolic extract was effective against L. major promastigotes in the mammalian cell line J774A.1 with SI = 2.514 (tail lesion size model). In silico analysis of identified compounds also revealed a favorable interaction between compounds 2 – 5 and L. major protein targets (3UIB, 4JZX, 4JZB, 5L4N, and 5L42). According to the findings of this study, the ethyl acetate fraction (as flavonoid fraction) exhibited considerable in vitro antileishmanial activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Parasitology and Mycology, School of Medicine Shiraz University of Medical Sciences, Shiraz, Iran.
- Basic Sciences in Infectious Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Pharmacognosy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Förderung
- Shiraz University of Medical Sciences
Zitieren
APA
Moradian, N., Hatam, G., Hamedi, A., & Pasdaran, A. (2023). In vitro and in vivo antileishmanial activity of the hanging sedge flavonoids based on bio‐ guided fractionation assay. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14226
Vancouver
Moradian N, Hatam G, Hamedi A, Pasdaran A. In vitro and in vivo antileishmanial activity of the hanging sedge flavonoids based on bio‐ guided fractionation assay. Chemical Biology & Drug Design. 2023. doi:10.1111/cbdd.14226
BibTeX
@article{Moradian2023,
author = {Moradian, Neda and Hatam, Gholamreza and Hamedi, Azadeh and Pasdaran, Ardalan},
title = {In vitro and in vivo antileishmanial activity of the hanging sedge flavonoids based on bio‐ guided fractionation assay},
journal = {Chemical Biology & Drug Design},
year = {2023},
doi = {10.1111/cbdd.14226}
}
EUVIMED